Globeimmune IncOver The Counter Market:GBIM
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Globeimmune Inc | 10.0 | 0.0x | --- |
Stemcell Holdings Inc | 1.6M | 750.0x | --- |
Athersys Inc | 277.7K | 0.0x | --- |
International Stem Cell Corp | 569.9K | -4.3x | --- |
Petros Pharmaceuticals Inc | 4.6M | -0.1x | --- |
Kineta Inc | 5.8M | -0.4x | --- |
Company Information
GlobeImmune Inc. is a biopharmaceutical company. The Company is focused on developing products for the treatment of cancer and infectious diseases based on its Tarmogen platform. The Company’s Tarmogen platform activates the immune system by stimulating a subset of white blood cells called T cells that destroy infected or malignant cells in contrast to traditional vaccines, which predominately stimulate antibody production. Tarmogens also reduce the number and function of regulatory T cells, thus further enabling the antigen-specific cellular immune response. It has over two Tarmogen product candidates in clinical evaluation for infectious disease and multiple cancer indications. The Company's oncology product candidates include GI-6301, GI-6207 and GI-4000. The Company's infectious disease product candidates include GS-4774, GI-19000, GI-2010 and GI-18000.
Contact Information
- Headquarters
- 1450 Infinite DriveLOUISVILLE, CO, United States 80027
- Phone
- 720-667-2300
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- J. William Freytag
- President, Chief Executive Officer, Director
- Timothy Rodell
- Vice President - Finance, Treasurer, Secretary
- C. Jeffrey Dekker
- Independent Director
- Augustine Lawlor
- Independent Director
- Daniel Mitchell
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.00 |
|---|---|
Revenue (TTM) | $6.2M |
Shares Outstanding | 5.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.39 |
Book Value | $0.52 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -33.30% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
